chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: The patient has not received her 2nd dose as the location stopped administrating the vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (The patient has not received her 2nd dose as the location stopped administrating the vaccine.) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (The patient has not received her 2nd dose as the location stopped administrating the vaccine.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (The patient has not received her 2nd dose as the location stopped administrating the vaccine.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Nausea, Pyrexia
Clinical narrative: Nauseous; She has been feeling tired; Throwing up; On same day, she had diarrhea after receiving 2nd dose; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (On same day, she had diarrhea after receiving 2nd dose), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nauseous) and FATIGUE (She has been feeling tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LAMOTRIGINE (LAMICTAL) and TRAZODONE for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced DIARRHOEA (On same day, she had diarrhea after receiving 2nd dose), PYREXIA (Fever), CHILLS (Chills) and VOMITING (Throwing up). On 06-Apr-2021, the patient experienced NAUSEA (Nauseous) and FATIGUE (She has been feeling tired). At the time of the report, DIARRHOEA (On same day, she had diarrhea after receiving 2nd dose), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nauseous), FATIGUE (She has been feeling tired) and VOMITING (Throwing up) outcome was unknown.            Concomitant medication also included BP medication. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Nauseous; She has been feeling tired; Throwing up; On same day, she had diarrhea after receiving 2nd dose; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (On same day, she had diarrhea after receiving 2nd dose), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nauseous) and FATIGUE (She has been feeling tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LAMOTRIGINE (LAMICTAL) and TRAZODONE for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced DIARRHOEA (On same day, she had diarrhea after receiving 2nd dose), PYREXIA (Fever), CHILLS (Chills) and VOMITING (Throwing up). On 06-Apr-2021, the patient experienced NAUSEA (Nauseous) and FATIGUE (She has been feeling tired). At the time of the report, DIARRHOEA (On same day, she had diarrhea after receiving 2nd dose), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nauseous), FATIGUE (She has been feeling tired) and VOMITING (Throwing up) outcome was unknown.            Concomitant medication also included BP medication. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Condition aggravated, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: Site of the shot is very warm; Although the arm dose not look like the typical Covid arm; Looks little pinkish and itchy; Looks little pinkish and itchy; Also its now moving further down the right arm; Cold sweats; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Also its now moving further down the right arm), COLD SWEAT (Cold sweats), VACCINATION SITE WARMTH (Site of the shot is very warm), VACCINATION SITE REACTION (Although the arm dose not look like the typical Covid arm) and VACCINATION SITE PRURITUS (Looks little pinkish and itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced COLD SWEAT (Cold sweats). On 03-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Site of the shot is very warm), VACCINATION SITE REACTION (Although the arm dose not look like the typical Covid arm), VACCINATION SITE PRURITUS (Looks little pinkish and itchy) and VACCINATION SITE ERYTHEMA (Looks little pinkish and itchy). In April 2021, the patient experienced CONDITION AGGRAVATED (Also its now moving further down the right arm). On 01-Apr-2021, COLD SWEAT (Cold sweats) had resolved. At the time of the report, CONDITION AGGRAVATED (Also its now moving further down the right arm), VACCINATION SITE WARMTH (Site of the shot is very warm), VACCINATION SITE REACTION (Although the arm dose not look like the typical Covid arm), VACCINATION SITE PRURITUS (Looks little pinkish and itchy) and VACCINATION SITE ERYTHEMA (Looks little pinkish and itchy) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-068878 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Site of the shot is very warm; Although the arm dose not look like the typical Covid arm; Looks little pinkish and itchy; Looks little pinkish and itchy; Also its now moving further down the right arm; Cold sweats; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Also its now moving further down the right arm), COLD SWEAT (Cold sweats), VACCINATION SITE WARMTH (Site of the shot is very warm), VACCINATION SITE REACTION (Although the arm dose not look like the typical Covid arm) and VACCINATION SITE PRURITUS (Looks little pinkish and itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced COLD SWEAT (Cold sweats). On 03-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Site of the shot is very warm), VACCINATION SITE REACTION (Although the arm dose not look like the typical Covid arm), VACCINATION SITE PRURITUS (Looks little pinkish and itchy) and VACCINATION SITE ERYTHEMA (Looks little pinkish and itchy). In April 2021, the patient experienced CONDITION AGGRAVATED (Also its now moving further down the right arm). On 01-Apr-2021, COLD SWEAT (Cold sweats) had resolved. At the time of the report, CONDITION AGGRAVATED (Also its now moving further down the right arm), VACCINATION SITE WARMTH (Site of the shot is very warm), VACCINATION SITE REACTION (Although the arm dose not look like the typical Covid arm), VACCINATION SITE PRURITUS (Looks little pinkish and itchy) and VACCINATION SITE ERYTHEMA (Looks little pinkish and itchy) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-068878 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Muscle spasms in her right arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms in her right arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Muscle spasms in her right arm). At the time of the report, MUSCLE SPASMS (Muscle spasms in her right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Arthralgia, Back pain
Clinical narrative: Pain on her right shoulder blade; Middle back pain; Hip pain; Lower stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (Lower stomach pain), BACK PAIN (Middle back pain), ARTHRALGIA (Hip pain) and ARTHRALGIA (Pain on her right shoulder blade) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 014M20A) for COVID-19 vaccination.     No medical history were provided by the reporter.  Concomitant products included LOSARTAN and SIMVASTATIN for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced ABDOMINAL PAIN LOWER (Lower stomach pain) and ARTHRALGIA (Hip pain). On 04-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BACK PAIN (Middle back pain). On 06-Apr-2021, the patient experienced ARTHRALGIA (Pain on her right shoulder blade). At the time of the report, ABDOMINAL PAIN LOWER (Lower stomach pain), BACK PAIN (Middle back pain), ARTHRALGIA (Hip pain) and ARTHRALGIA (Pain on her right shoulder blade) outcome was unknown. Not Provided          Treatment drugs not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Swelling
Clinical narrative: Delayed rash on arm; Itchy rash; Bump in rash; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Bump in rash), RASH (Delayed rash on arm) and RASH PRURITIC (Itchy rash) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 immunisation.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced SWELLING (Bump in rash). On 02-Apr-2021, the patient experienced RASH (Delayed rash on arm) and RASH PRURITIC (Itchy rash). At the time of the report, SWELLING (Bump in rash), RASH (Delayed rash on arm) and RASH PRURITIC (Itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Limb discomfort
Clinical narrative: pain in upper back; pain in chest area; legs began to heavy; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in upper back), CHEST PAIN (pain in chest area) and LIMB DISCOMFORT (legs began to heavy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (pain in upper back), CHEST PAIN (pain in chest area) and LIMB DISCOMFORT (legs began to heavy). At the time of the report, BACK PAIN (pain in upper back), CHEST PAIN (pain in chest area) and LIMB DISCOMFORT (legs began to heavy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Nausea
Clinical narrative: Ached all over; Weak; Headache; Nauseous; Feels very tired; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ached all over), ASTHENIA (Weak), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Feels very tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (Chills). On 04-Apr-2021, the patient experienced PAIN (Ached all over), ASTHENIA (Weak), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Feels very tired). On 03-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN (Ached all over), ASTHENIA (Weak), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Feels very tired) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication was reported.  Treatment medication was not provided by the reporter.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Ached all over; Weak; Headache; Nauseous; Feels very tired; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ached all over), ASTHENIA (Weak), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Feels very tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (Chills). On 04-Apr-2021, the patient experienced PAIN (Ached all over), ASTHENIA (Weak), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Feels very tired). On 03-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN (Ached all over), ASTHENIA (Weak), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (Feels very tired) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication was reported.  Treatment medication was not provided by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus, Rash erythematous
Clinical narrative: Red rash on right arm; Itchiness on right arm; Hotness in right arm / Hot and warm face; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash on right arm), PRURITUS (Itchiness on right arm) and FEELING HOT (Hotness in right arm / Hot and warm face) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3001176) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PERINDOPRIL for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on right arm), PRURITUS (Itchiness on right arm) and FEELING HOT (Hotness in right arm / Hot and warm face). At the time of the report, RASH ERYTHEMATOUS (Red rash on right arm), PRURITUS (Itchiness on right arm) and FEELING HOT (Hotness in right arm / Hot and warm face) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included application of  ice on arm.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Little pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little pain at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Little pain at injection site). At the time of the report, VACCINATION SITE PAIN (Little pain at injection site) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-068840 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Joint stiffness, Pyrexia
Clinical narrative: Joint stiffness; sweating; chills; vaccination site pain; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Joint stiffness), HYPERHIDROSIS (sweating), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced JOINT STIFFNESS (Joint stiffness), HYPERHIDROSIS (sweating), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain), PYREXIA (fever) and FATIGUE (fatigue). The patient was treated with ACETAMINOPHEN ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, JOINT STIFFNESS (Joint stiffness), HYPERHIDROSIS (sweating), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.            No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-062200 (E2B Linked Report).; Sender's Comments:  MOD-2021-062200:1dose
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Joint stiffness; sweating; chills; vaccination site pain; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Joint stiffness), HYPERHIDROSIS (sweating), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced JOINT STIFFNESS (Joint stiffness), HYPERHIDROSIS (sweating), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain), PYREXIA (fever) and FATIGUE (fatigue). The patient was treated with ACETAMINOPHEN ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, JOINT STIFFNESS (Joint stiffness), HYPERHIDROSIS (sweating), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.            No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-062200 (E2B Linked Report).; Sender's Comments:  MOD-2021-062200:1dose
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema
Clinical narrative: Itchiness; Redness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness around injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PRAVASTATIN, AMLODIPINE, VALSARTAN, MONTELUKAST, CENTRUM SILVER +50 and COLECALCIFEROL (VIT D3) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness around injection site). The patient was treated with TRIAMCINOLONE at an unspecified dose and frequency; HALOBETASOL PROPIONATE at an unspecified dose and frequency; CYCLOSPORINE at an unspecified dose and frequency; METHOTREXATE SODIUM at an unspecified dose and frequency and FOLIC ACID at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness around injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-068925 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-MAY-2021 contains non-significant information (contact information updated).
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Swelling
Clinical narrative: rash; itchy; swelling; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash), PRURITUS (itchy) and SWELLING (swelling) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE, LIOTHYRONINE, CALCIUM, MULTIVITAMINS & MINERALS PLUS LUTEIN, Bupropion XL, Adderall XR,  REPAGLINIDE (PAGE) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced RASH (rash), PRURITUS (itchy) and SWELLING (swelling). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Myalgia, Pain in jaw, Swelling
Clinical narrative: Mandibular tender to touch; Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen; Pain in my left armpit; Swollen Lymph nodes; Injection arm was sore; Injection arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection arm was sore), SWELLING (Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen), PAIN IN JAW (Mandibular tender to touch), AXILLARY PAIN (Pain in my left armpit) and MYALGIA (Injection arm was sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection arm was sore) and MYALGIA (Injection arm was sore). On 24-Mar-2021 at 2:20 AM, the patient experienced AXILLARY PAIN (Pain in my left armpit). 24-Mar-2021 at 2:20 AM, the patient experienced LYMPHADENOPATHY (Swollen Lymph nodes). On 04-Apr-2021, the patient experienced SWELLING (Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen). On an unknown date, the patient experienced PAIN IN JAW (Mandibular tender to touch). The patient was treated with IBUPROFEN for Axillary pain, at a dose of 1 UNK. At the time of the report, VACCINATION SITE PAIN (Injection arm was sore), SWELLING (Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen), PAIN IN JAW (Mandibular tender to touch), AXILLARY PAIN (Pain in my left armpit), MYALGIA (Injection arm was sore) and LYMPHADENOPATHY (Swollen Lymph nodes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient stated that she had an appointment with her doctor on 07-Apr-2021.The patient stated that she took her second vaccine on 23-Apr-2021 and experienced some adverse events.   This case was linked to MOD-2021-258052 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Updated dose 2 details and new events were added corresponding to dose 2. On 27-May-2021: Translation received on 05-Jul-2021 and does not contain any new information. On 30-Jul-2021: Translation received on 09-Aug-2021 as event outcome updated for all events.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mandibular tender to touch; Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen; Pain in my left armpit; Swollen Lymph nodes; Injection arm was sore; Injection arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection arm was sore), SWELLING (Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen), PAIN IN JAW (Mandibular tender to touch), AXILLARY PAIN (Pain in my left armpit) and MYALGIA (Injection arm was sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection arm was sore) and MYALGIA (Injection arm was sore). On 24-Mar-2021 at 2:20 AM, the patient experienced AXILLARY PAIN (Pain in my left armpit). 24-Mar-2021 at 2:20 AM, the patient experienced LYMPHADENOPATHY (Swollen Lymph nodes). On 04-Apr-2021, the patient experienced SWELLING (Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen). On an unknown date, the patient experienced PAIN IN JAW (Mandibular tender to touch). The patient was treated with IBUPROFEN for Axillary pain, at a dose of 1 UNK. At the time of the report, VACCINATION SITE PAIN (Injection arm was sore), SWELLING (Chest and neck area became swollen/ Face to her breast region feels swollen/Feels like the inside of her ears are swollen), PAIN IN JAW (Mandibular tender to touch), AXILLARY PAIN (Pain in my left armpit), MYALGIA (Injection arm was sore) and LYMPHADENOPATHY (Swollen Lymph nodes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient stated that she had an appointment with her doctor on 07-Apr-2021.The patient stated that she took her second vaccine on 23-Apr-2021 and experienced some adverse events.   This case was linked to MOD-2021-258052 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Updated dose 2 details and new events were added corresponding to dose 2. On 27-May-2021: Translation received on 05-Jul-2021 and does not contain any new information. On 30-Jul-2021: Translation received on 09-Aug-2021 as event outcome updated for all events.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: she had diarrhea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (she had diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced DIARRHOEA (she had diarrhea). At the time of the report, DIARRHOEA (she had diarrhea) outcome was unknown.            Relevant Text: The reporter was a Spanish caller and reported that the patient received their 1st dose on 02 Feb 2021 and the 2nd dose on 02 Mar 2021. After receiving the vaccine that patient had diarrhea on an unspecified date and visited the doctor. The patient reported that they were tested and had no antibodies. No more information was provided by the reporter.  Lab information:   No Concomitant product use was reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated
Clinical narrative: Condition worsened; This spontaneous case was reported by an other and describes the occurrence of CONDITION AGGRAVATED (Condition worsened) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Spinal muscular atrophy. Concomitant products included RISDIPLAM (EVRYSDI) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (Condition worsened). At the time of the report, CONDITION AGGRAVATED (Condition worsened) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had  experienced Interaction with COVID-19 vaccine, patient's all progress made on Evrysdi "disappeared within 24 hours" of the Moderna COVID-19. vaccine   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow-up received and contain non-significant information.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Pain, Pyrexia, Rash, Rash macular
Clinical narrative: Red blotches around his whole body; Looks like sunburn; shedding skin constantly; White blisters on body; Aches/ Pain; Rash/rash for 4 months; Fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Red blotches around his whole body), SUNBURN (Looks like sunburn), SKIN EXFOLIATION (shedding skin constantly), BLISTER (White blisters on body) and PAIN (Aches/ Pain) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A27A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PRAVASTATIN, AMLODIPINE, VALSARTAN, MONTELUKAST, VITAMIN D3 and CENTRUM SILVER [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;FOLIC ACID;IODINE;IRON;LYCOPENE;MAGNESIUM;MANGANESE;NICOTINAMIDE;PANTOTHENIC ACID;PHOSPHORUS;PHYTOMENADIONE;POTASSIUM;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Red blotches around his whole body), SUNBURN (Looks like sunburn), SKIN EXFOLIATION (shedding skin constantly), BLISTER (White blisters on body), PAIN (Aches/ Pain), RASH (Rash/rash for 4 months) and PYREXIA (Fever). The patient was treated with TRIAMCINOLONE at a dose of 1 dosage form; HALOBETASOL PROPIONATE at a dose of 1 dosage form; CYCLOSPORINE at a dose of 1 dosage form; METHOTREXATE SODIUM at a dose of 1 dosage form and FOLIC ACID at a dose of 1 dosage form. At the time of the report, RASH MACULAR (Red blotches around his whole body), SUNBURN (Looks like sunburn), SKIN EXFOLIATION (shedding skin constantly), BLISTER (White blisters on body), PAIN (Aches/ Pain), RASH (Rash/rash for 4 months) and PYREXIA (Fever) outcome was unknown.       This case was linked to MOD-2021-068887 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25 May 2021 contains non-significant information : Updated contact information. On 28-Jun-2021: Follow-up received on28-jun-2021.updated events.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Skin exfoliation, Sunburn
Clinical narrative: Red blotches around his whole body; Looks like sunburn; shedding skin constantly; White blisters on body; Aches/ Pain; Rash/rash for 4 months; Fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Red blotches around his whole body), SUNBURN (Looks like sunburn), SKIN EXFOLIATION (shedding skin constantly), BLISTER (White blisters on body) and PAIN (Aches/ Pain) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A27A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PRAVASTATIN, AMLODIPINE, VALSARTAN, MONTELUKAST, VITAMIN D3 and CENTRUM SILVER [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;FOLIC ACID;IODINE;IRON;LYCOPENE;MAGNESIUM;MANGANESE;NICOTINAMIDE;PANTOTHENIC ACID;PHOSPHORUS;PHYTOMENADIONE;POTASSIUM;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Red blotches around his whole body), SUNBURN (Looks like sunburn), SKIN EXFOLIATION (shedding skin constantly), BLISTER (White blisters on body), PAIN (Aches/ Pain), RASH (Rash/rash for 4 months) and PYREXIA (Fever). The patient was treated with TRIAMCINOLONE at a dose of 1 dosage form; HALOBETASOL PROPIONATE at a dose of 1 dosage form; CYCLOSPORINE at a dose of 1 dosage form; METHOTREXATE SODIUM at a dose of 1 dosage form and FOLIC ACID at a dose of 1 dosage form. At the time of the report, RASH MACULAR (Red blotches around his whole body), SUNBURN (Looks like sunburn), SKIN EXFOLIATION (shedding skin constantly), BLISTER (White blisters on body), PAIN (Aches/ Pain), RASH (Rash/rash for 4 months) and PYREXIA (Fever) outcome was unknown.       This case was linked to MOD-2021-068887 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25 May 2021 contains non-significant information : Updated contact information. On 28-Jun-2021: Follow-up received on28-jun-2021.updated events.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Vaccination site pain
Clinical narrative: Headache; Arm tenderness; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE, VACCINATION SITE PAIN, NAUSEA, and CHILLS in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced HEADACHE, VACCINATION SITE PAIN, NAUSEA, and CHILLS. At the time of the report, HEADACHE, VACCINATION SITE PAIN, NAUSEA, and CHILLS outcome was unknown. Not Provided.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Pollakiuria
Clinical narrative: Diarrhea; Frequent urination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and POLLAKIURIA (Frequent urination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea) and POLLAKIURIA (Frequent urination). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasopharyngitis
Clinical narrative: Cold/ Stuffy nose; Cough; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold/ Stuffy nose) and COUGH (Cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold/ Stuffy nose) and COUGH (Cough). At the time of the report, NASOPHARYNGITIS (Cold/ Stuffy nose) and COUGH (Cough) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Reporter did not allow further contact
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant; This case was initially received via Agency (Reference number: US-irms-MOD21-126767) on 06-Apr-2021. The most recent information was received on 05-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 34-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-Aug-2020 and the estimated date of delivery was 08-May-2021. On 05-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  On 05-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient were not provided. On an unknown date, the patient received a positive pregnancy test and date of conception was not provided.  On 05 Apr 2021, the pregnant patient was exposed to the mRNA -1273 vaccine. Treatment information was not provided.     Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Patient route of administration added
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache
Clinical narrative: pain in back; headache; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in back) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced BACK PAIN (pain in back) and HEADACHE (headache). At the time of the report, BACK PAIN (pain in back) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. Treatment information not was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyskinesia, Feeling abnormal, Insomnia
Clinical narrative: Red rash on her Pinkie; Could not move the Right Arm; Room Spinning if Lying Down (Dizziness); Nausea (Only when she feels Dizziness); Muscles in her face were moving in different directions; Burning Sensation at the Injection Site; Swollen Injection Site; Hot to touch Injection Site; Bruise Injection Site (Quarter Size); Prolonged Bleeding Injection Site; Severe Chills; Lack of Sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)) and VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, LIOTHYRONINE (NP THYROID), PROGESTERONE (PROGESTERON BESINS), ESTROGEN NOS and TESTOSTERONE for Menopause.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)), VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site), CHILLS (Severe Chills), INSOMNIA (Lack of Sleep) and FEELING ABNORMAL (Muscles in her face were moving in different directions). On 14-Mar-2021, the patient experienced DYSKINESIA (Could not move the Right Arm), DIZZINESS (Room Spinning if Lying Down (Dizziness)) and NAUSEA (Nausea (Only when she feels Dizziness)). On 01-Apr-2021, the patient experienced RASH (Red rash on her Pinkie). On 13-Mar-2021, VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)), VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site), CHILLS (Severe Chills), INSOMNIA (Lack of Sleep) and FEELING ABNORMAL (Muscles in her face were moving in different directions) had resolved. On 03-Apr-2021, DYSKINESIA (Could not move the Right Arm) had resolved. At the time of the report, DIZZINESS (Room Spinning if Lying Down (Dizziness)), NAUSEA (Nausea (Only when she feels Dizziness)) and RASH (Red rash on her Pinkie) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.